Table 1.

Prevalence (%) and corresponding Prevalence Ratio (PR) of SpA-related comorbidities in AS, PsA and uSpA

AS casesPR (95% CI)PsA casesPR (95% CI)uSpA casesPR (95% CI)
n (%)(AS: GP)n (%)(PsA: GP)n (%)(uSpA: GP)
Females, n (%) 1217 (31.3) 4772 (54.8) 1503 (56.4)
Age, mean ±SD 51.1±12.7 53.9±13.5 46.1±12.8
IBD350 (9.0)9.3 (7.7–11.2)180 (2.1)1.9 (1.6–2.3)139 (5.2)5.2 (4.1–6.6)
– Crohn's disease170 (4.4)11.6 (8.7–15.4)78 (0.9)2.2 (1.7–2.9)62 (2.3)6.5 (4.4–9.6)
– Ulcerative colitis180 (4.6)7.8 (6.2–10.0)102 (1.2)1.8 (1.4–2.3)77 (2.9)4.4 (3.3–6.1)
Anterior uveitis819 (21.1)44.8 (35.7–56.3)145 (1.7)3.8 (3.1–4.8)351 (13.2)32.4 (24.1–43.6)
Psoriasis85 (2.2)2.7 (2.0–3.5)NANA78 (2.9)3.2 (2.4–4.3)
AV block39 (1.0)5.8 (3.6–9.4)30 (0.3)1.6 (1.0–2.4)13 (0.5)4.6 (2.1–10.0)
Aortic regurgitation*55 (1.4)4.7 (3.2–6.9)41 (0.5)1.7 (1.2–2.4)11 (0.4)3.0 (1.4–6.4)
  • AV, atrioventricular; NA, not applicable. *Aortic regurgitation includes both ICD codes for aortic regurgitation and procedure codes for aortic valve surgery.